Health Care & Life Sciences » Pharmaceuticals | Chongqing Lummy Pharmaceutical Co. Ltd.

Chongqing Lummy Pharmaceutical Co. Ltd. | Ownership

Companies that own Chongqing Lummy Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Golden Eagle Asset Management Co., Ltd.
21,000,000
3.59%
21,000,000
0.38%
03/31/2018
GF Fund Management Co., Ltd.
295,400
0.05%
27,200
0%
12/31/2017
BlackRock Asset Management North Asia Ltd.
33,500
0.01%
0
0%
01/31/2018
Da Cheng Fund Management Co., Ltd.
32,700
0.01%
16,200
0%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
14,200
0%
0
0%
12/31/2017
China Southern Asset Management Co., Ltd.
11,900
0%
200
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
7,738
0%
-1,400
0%
12/31/2017
Chang Xin Asset Management Co., Ltd.
0
0%
-94,420
0%
12/31/2017
China Merchants Fund Management Co., Ltd.
0
0%
-2,452,731
0%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
0
0%
-1,329,600
0%
12/31/2017

About Chongqing Lummy Pharmaceutical Co.

View Profile
Address
15th Floor, Tower B
Chongqing Chongqing 401123
China
Employees -
Website http://www.cqlummy.com
Updated 07/08/2019
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agent, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China.